These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27026046)

  • 1. MMP9 Promoter Polymorphism (-1562 C/T) Does not Affect the Serum Levels of Soluble MICB and MICA in Breast Cancer.
    Bargostavan MH; Eslami G; Esfandiari N; Shams Shahemabadi A
    Iran J Immunol; 2016 Mar; 13(1):45-53. PubMed ID: 27026046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diversity and characterization of polymorphic 5' promoter haplotypes of MICA and MICB genes.
    Cox ST; Madrigal JA; Saudemont A
    Tissue Antigens; 2014 Sep; 84(3):293-303. PubMed ID: 24962621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
    Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
    Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of MICA-TM and MICB C1_2_A microsatellite polymorphisms with tumor progression in patients with colorectal cancer.
    Kopp R; Glas J; Lau-Werner U; Albert ED; Weiss EH
    J Clin Immunol; 2009 Jul; 29(4):545-54. PubMed ID: 19353249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
    Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
    Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum level of matrix metalloproteinase 9 and promoter polymorphism - 1562 C:T as a new risk factor for metabolic syndrome.
    Yadav SS; Mandal RK; Singh MK; Verma A; Dwivedi P; Sethi R; Usman K; Khattri S
    DNA Cell Biol; 2014 Nov; 33(11):816-22. PubMed ID: 25211325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput
    Klussmeier A; Massalski C; Putke K; Schäfer G; Sauter J; Schefzyk D; Pruschke J; Hofmann J; Fürst D; Carapito R; Bahram S; Schmidt AH; Lange V
    Front Immunol; 2020; 11():314. PubMed ID: 32153595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship between major histocompatibility complex class I chain-related antigens A (MICA)-129 gene polymorphism, soluble MICA level and ulcerative colitis].
    Zhao J; Jiang Y; Lei Y; Chen LP; Yi FM; Wang CG; Zou KF; Xia B
    Zhonghua Nei Ke Za Zhi; 2011 Apr; 50(4):311-5. PubMed ID: 21600151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of Matrix Metalloproteinase-9 Promoter Genotypes on Asthma Risk.
    Chiu KL; He JL; Chen GL; Shen TC; Chen LH; Chen JC; Tsai CW; Chang WS; Hsia TC; Bau DT
    In Vivo; 2024; 38(5):2144-2151. PubMed ID: 39187355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients.
    Salih HR; Goehlsdorf D; Steinle A
    Hum Immunol; 2006 Mar; 67(3):188-95. PubMed ID: 16698441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population.
    Mariaselvam CM; Boukouaci W; Charron D; Krishnamoorthy R; Tamouza R; Misra DP; Negi VS
    Int J Rheum Dis; 2018 Mar; 21(3):656-663. PubMed ID: 28752674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity and characterisation of polymorphic 3' untranslated region haplotypes of MICA and MICB genes.
    Cox ST; Hernandez D; Danby R; Turner TR; Madrigal JA
    HLA; 2018 Dec; 92(6):392-402. PubMed ID: 30471210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary investigation of MMP8 (rs11225395) and MMP9 (rs3787268) polymorphisms association with breast cancer risk in pashtun women of Pakistan.
    Khan S; Khan NU; Khan Y; Shehzad I; Alanzi AR; Chen T
    Mol Biol Rep; 2024 Oct; 51(1):1034. PubMed ID: 39361067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of MMP9-1562C/T and MMP13-77A/G Polymorphisms with Non-Small Cell Lung Cancer in Southern Chinese Population.
    Li W; Jia MX; Wang JH; Lu JL; Deng J; Tang JX; Liu C
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30889876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Ohkawa K; Miyagi T; Hiramatsu N; Kanto T; Kasugai T; Katayama K; Kato M; Hayashi N
    Cancer Sci; 2008 Aug; 99(8):1643-9. PubMed ID: 18754878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA.
    Holdenrieder S; Stieber P; Peterfi A; Nagel D; Steinle A; Salih HR
    Cancer Immunol Immunother; 2006 Dec; 55(12):1584-9. PubMed ID: 16636811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between MMP-9 promoterpolymorphism and IVF outcome.
    Shabanipour S; Mashayekhi F; Bahadori MH; Soruri ZZ
    Cell Mol Biol (Noisy-le-grand); 2015 Mar; 61(1):64-7. PubMed ID: 25817348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional SNP -1562C/T in the promoter region of MMP9 and recurrent early pregnancy loss.
    Singh K; Nair RR; Khanna A
    Reprod Biomed Online; 2012 Jan; 24(1):61-5. PubMed ID: 22118839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.